Mitral Regurgitation Clinical Trials in Charlotte, North Carolina

5 studies are recruiting for mitral regurgitation in Charlotte, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Cephea Early Feasibility Study

    The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Atrium Health - Carolinas Medical Center, Charlotte, North Carolina
    Locations
    22 in total
    Run by
    Abbott Medical Devices

    See if you can join NCT05061004 on ClinicalTrials.gov

  2. Abbott Cephea Mitral Valve Disease Registry

    The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of co…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Atrium Health - Carolinas Medical Center, Charlotte, North Carolina
    Locations
    24 in total
    Run by
    Abbott Medical Devices

    See if you can join NCT07069673 on ClinicalTrials.gov

  3. ATLAS (AltaValve) Pivotal Trial

    This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population.

    Stage
    Not phased
    Ages
    18 and older
    Site
    The Charlotte-Mecklenburg Hospital; Atrium Health, Charlotte, North Carolina
    Locations
    58 in total
    Run by
    4C Medical Technologies, Inc.

    See if you can join NCT06465745 on ClinicalTrials.gov

  4. The ENCIRCLE Trial

    This study will establish the safety and effectiveness of the SAPIEN M3 System in subjects with symptomatic, at least 3+ mitral regurgitation (MR) for whom commercially available surgical or transcatheter treatment options are deemed unsuitable. Following completion of enrollment, subjects will be …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Carolinas Medical Center, Charlotte, North Carolina
    Locations
    68 in total
    Run by
    Edwards Lifesciences

    See if you can join NCT04153292 on ClinicalTrials.gov

  5. EFS of the CardioMech MVRS

    Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Atrium Health Sanger Heart and Vascular Institute, Charlotte, North Carolina
    Locations
    12 in total
    Run by
    CardioMech AS

    See if you can join NCT04820764 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.